These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15816800)

  • 1. Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study.
    Schutters SI; van Megen HJ; Westenberg HG
    J Clin Psychiatry; 2005 Apr; 66(4):540-2. PubMed ID: 15816800
    [No Abstract]   [Full Text] [Related]  

  • 2. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
    Villeneuve E; Lemelin S
    J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine in the treatment of rapid-cycling bipolar II disorder with comorbid anxiety and social phobia -- a case report.
    Valerius G; Biedermann NC; Schaerer LO; Langosch JM
    Pharmacopsychiatry; 2005 Sep; 38(5):225-6. PubMed ID: 16189752
    [No Abstract]   [Full Text] [Related]  

  • 4. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
    J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression.
    Galynker I; Khan A; Grebchenko Y; Ten A; Malaya L; Yanowitch P; Cohen LJ
    J Clin Psychiatry; 2005 Apr; 66(4):544. PubMed ID: 15816805
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder.
    Citrome L; Krakowski M; Greenberg WM; Andrade E; Volavka J
    J Clin Psychiatry; 2001 Nov; 62(11):901. PubMed ID: 11775051
    [No Abstract]   [Full Text] [Related]  

  • 9. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.
    Bandelow B; Chouinard G; Bobes J; Ahokas A; Eggens I; Liu S; Eriksson H
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):305-20. PubMed ID: 19691907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolated fear of frogs and toads--a case of bufono-ranophobia].
    Koch HJ; Gehring C
    MMW Fortschr Med; 2012 Jun; 154(11):63-4. PubMed ID: 22838136
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute anxiolytic effects of quetiapine during virtual reality exposure--a double-blind placebo-controlled trial in patients with specific phobia.
    Diemer J; Domschke K; Mühlberger A; Winter B; Zavorotnyy M; Notzon S; Silling K; Arolt V; Zwanzger P
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1551-60. PubMed ID: 23375006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine and essential tremor.
    Micheli F; Cersósimo MG; Raina G; Gatto E
    Clin Neuropharmacol; 2002; 25(6):303-6. PubMed ID: 12469002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on "Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study)" by Dr Thase and colleagues.
    Dawdy P
    J Clin Psychopharmacol; 2008 Jun; 28(3):367-8; author reply 368. PubMed ID: 18480707
    [No Abstract]   [Full Text] [Related]  

  • 14. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
    McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
    J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of quetiapine vs. placebo on response to two virtual public speaking exposures in individuals with social phobia.
    Donahue CB; Kushner MG; Thuras PD; Murphy TG; Van Demark JB; Adson DE
    J Anxiety Disord; 2009 Apr; 23(3):362-8. PubMed ID: 19157776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine in patients with Tourette's disorder: an open-label, flexible-dose study.
    de Jonge JL; Cath DC; van Balkom AJ
    J Clin Psychiatry; 2007 Jul; 68(7):1148-50. PubMed ID: 17685760
    [No Abstract]   [Full Text] [Related]  

  • 18. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
    J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study.
    Gabriel A
    Clin Ter; 2011; 162(2):113-8. PubMed ID: 21533316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
    Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
    Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.